Important Notice for Intellia Therapeutics Shareholders
The Gross Law Firm has issued a crucial reminder to shareholders of Intellia Therapeutics, Inc. (NASDAQ: NTLA) regarding an impending class action lawsuit. This notice is particularly relevant for investors who acquired shares of NTLA during a designated timeframe and are encouraged to participate in this legal action.
Class Action Lawsuit Details
The class action period in question spans from July 30, 2024, to January 8, 2025. Allegations state that during this period, Intellia’s executives made misleading statements regarding the company's progress in their Phase 1/2 study, focused on developing treatments for alpha-1 antitrypsin deficiency (AATD)-related lung disease.
It was claimed that the management expressed confidence in the firm's progress and timelines for administering doses to patients. However, it was later revealed that the scientific community was pivoting towards non-viral delivery systems due to their cost-effectiveness and efficiency, effectively rendering Intellia's NTLA-3001 program less viable.
Consequences and Market Impact
On January 9, 2025, the company announced significant restructuring, including discontinuing research related to NTLA-3001 and laying off 27% of its workforce. This announcement led to a notable drop in share prices, plummeting from $12.02 on January 8, 2025, to $10.20 by January 10, 2025 — a clear indication of investors reacting to the unveiled truths about the company's fate.
Next Steps for Shareholders
Shareholders who purchased shares of NTLA during the specified period are urged to register for the class action before the lead plaintiff deadline of April 14, 2025. There is no requirement to be a lead plaintiff to participate in potential recoveries as part of this case. By registering, affected shareholders can also enroll in a monitoring system that will provide updates throughout the case's progress.
Interested investors can initiate their registration through the Gross Law Firm's dedicated link,
Intellia Loss Submission Form.
Why Choose Gross Law Firm?
The Gross Law Firm stands as a respected entity in handling class action lawsuits, prioritizing the rights of investors who have suffered losses due to misleading information from corporations. Their commitment is reflected in their pursuit of justice for investors who encounter issues stemming from fraud and deceptive business tactics.
In their efforts, the firm fortifies its dedication to corporate accountability and ethical practices in business, ensuring companies face repercussions for misleading statements that inflate stock values artificially.
Contact Information
For additional details or inquiries, shareholders may reach out to the Gross Law Firm directly at their New York office:
- - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
- - Email: info@grosslawfirm.com
- - Phone: (646) 453-8903
As the deadline approaches, shareholders are urged to act swiftly to assert their rights and be part of the unfolding legal processes.
Stay informed and protected. Don’t hesitate to take the necessary steps for your investments.